AstraZeneca Sued For $1.3B Over Failed Drug Deal
A San Diego pharmaceutical company has filed a $1.28 billion lawsuit accusing AstraZeneca AB of backing out of a deal to develop a pediatric asthma treatment and then working to stop...To view the full article, register now.
Already a subscriber? Click here to view full article